Market Overview

UPDATE: Deutsche Bank Upgrades Acadia Healthcare to Buy; Compelling Growth Momentum

Share:
Related ACHC
14 Health Care, Managed Care Stocks To Put On Your Radar
Analyst: Don't Buy The Weakness In Acadia Healthcare
Bain Capital Investors Llc Buys Surgery Partners Inc, Sells Acadia Healthcare Co Inc (GuruFocus)

Deutsche Bank raises its rating on Acadia Healthcare (NASDAQ: ACHC) from Hold to Buy and increases its price target from $15 to $19.

Deutsche Bank comments, "Our stance upon initiation of coverage (Jan 2012) was simple: growth will be good but the shares may pull back and offer a better entry point. With the recent equity offering, the balance sheet and capacity to accretively acquire put it in a place where the next meaningful N-T move in the shares is likely to be up and not down, in our view. Given the growth outlook and improved capital structure, we believe a higher multiple is warranted (we go from 8.5x to 9.5x 2013E EV/EBITDA or 20x P/E) bringing our PT to $19 from $15."

ACHC closed at $16.51 on Wednesday.

Latest Ratings for ACHC

DateFirmActionFromTo
Nov 2017Credit SuisseInitiates Coverage OnNeutral
Oct 2017MizuhoDowngradesBuyNeutral
Oct 2017BMO CapitalMaintainsOutperform

View More Analyst Ratings for ACHC
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Upgrades Price Target Intraday Update Analyst Ratings

 

Related Articles (ACHC)

View Comments and Join the Discussion!

Partner Center